Cargando…
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities
As of January 2021, SARS-CoV-2 has killed over 2 million individuals across the world. As such, there is an urgent need for vaccines and therapeutics to reduce the burden of COVID-19. Several vaccines, including mRNA, vector-based vaccines, and inactivated vaccines, have been approved for emergency...
Autores principales: | Wehbe, Zena, Wehbe, Maya, Iratni, Rabah, Pintus, Gianfranco, Zaraket, Hassan, Yassine, Hadi M., Eid, Ali H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043070/ https://www.ncbi.nlm.nih.gov/pubmed/33859652 http://dx.doi.org/10.3389/fimmu.2021.663586 |
Ejemplares similares
-
Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality
por: Wehbe, Zena, et al.
Publicado: (2021) -
Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications
por: Giordo, Roberta, et al.
Publicado: (2022) -
Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling
por: Wehbe, Zena, et al.
Publicado: (2020) -
Pharmacological and Antioxidant Activities of Rhus coriaria L. (Sumac)
por: Alsamri, Halima, et al.
Publicado: (2021) -
Macrophage responses associated with COVID-19: A pharmacological perspective
por: Booz, George W., et al.
Publicado: (2020)